LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. (2291.HK)
HKD 24.1
(4.78%)
HKD 24.1
(4.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | 164.25 Million | 65.53 Million | 105.27 Million | 59.09 Million | 54.47 Million |
| Net Income | 173.29 Million | -15.03 Million | 66.02 Million | 76.67 Million | 51.9 Million |
| Depreciation & Amortization | 15.7 Million | 14.86 Million | 9.8 Million | 6.11 Million | 4.71 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | 21.05 Million | 20.51 Million | 17.8 Million | - | - |
| Change in working capital | -1.78 Million | -48.73 Million | 13.84 Million | -3.13 Million | -22.53 Million |
| Other non-cash items | -14.61 Million | 12.82 Million | 9.52 Million | -975 Thousand | 20.38 Million |
| Investing Cash Flow | 111.31 Million | -406 Million | -85.17 Million | -8.46 Million | -13.07 Million |
| Investments in PPE | -86.74 Million | -83.36 Million | -91.84 Million | -15.66 Million | -3.26 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | -1.33 Billion | -5.91 Billion | -3.27 Billion | - | - |
| Sales/Maturities of investments | 1.53 Billion | 5.59 Billion | 3.28 Billion | 1.04 Million | - |
| Other Investing Activities | 114.38 Million | -392.72 Million | -62.71 Million | -5.93 Million | -9.8 Million |
| Financing Cash Flow | -2.04 Million | 577.8 Million | 672.22 Million | -47.96 Million | -41.86 Million |
| Debt repayment | -2.04 Million | -3.63 Million | -2.37 Million | -492 Thousand | -483 Thousand |
| Dividends payments | - | - | -320 Million | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | - | 601.62 Million | - | - | - |
| Other Financing Activities | -2.04 Million | 581.43 Million | 996.28 Million | -47.46 Million | -41.38 Million |
| Accounts receivables | 4.05 Million | -12.02 Million | 13.5 Million | 8.16 Million | -15.87 Million |
| Accounts payables | - | - | - | - | - |
| Inventory | -12.02 Million | -23.99 Million | -10.08 Million | -12.26 Million | -1.42 Million |
| Other working capital | 3.46 Million | -18.96 Million | 1.72 Million | -7.02 Million | -5.24 Million |
| Cash at beginning of period | 944.51 Million | 713.48 Million | 18.79 Million | 16.11 Million | 16.58 Million |
| Cash at end of period | 1.21 Billion | 944.51 Million | 713.48 Million | 18.79 Million | 16.11 Million |
| Capital Expenditure | -86.74 Million | -83.36 Million | -91.84 Million | -15.66 Million | -3.26 Million |
| Effect of forex changes on cash | -6 Million | -6.29 Million | 2.35 Million | - | - |
| Net cash flow / Change in cash | 267.51 Million | 231.03 Million | 694.68 Million | 2.67 Million | -463 Thousand |
| Free Cash Flow | 77.51 Million | -17.82 Million | 13.43 Million | 43.43 Million | 51.2 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 140.22 Million | 173.29 Million | 75.43 Million | 76.09 Million | -44.06 Million | -15.03 Million |
| Depreciation & Amortization | 8.66 Million | 15.7 Million | 7.67 Million | 8.02 Million | 8.08 Million | 14.86 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 8.01 Million | 21.05 Million | 10.59 Million | 10.45 Million | 13.41 Million | 20.51 Million |
| Change in working capital | - | -1.78 Million | -4.5 Million | - | -54.98 Million | -48.73 Million |
| Other non-cash items | -53.41 Million | -14.61 Million | 13.39 Million | -32.91 Million | 90.41 Million | 12.82 Million |
| Investing Cash Flow | -231.01 Million | 111.31 Million | 47.45 Million | 63.86 Million | -303.23 Million | -406 Million |
| Investments in PPE | -31 Million | -86.74 Million | -1.86 Million | -1.2 Million | -3.82 Million | -83.36 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | -1.33 Billion | - | - | - | -5.91 Billion |
| Sales/Maturities of investments | - | 1.53 Billion | - | - | - | 5.59 Billion |
| Other Investing Activities | -200.01 Million | 114.38 Million | 49.31 Million | 65.07 Million | -299.41 Million | -392.72 Million |
| Financing Cash Flow | -895.21 Thousand | -2.04 Million | -1.25 Million | -794 Thousand | 580.03 Million | 577.8 Million |
| Debt repayment | - | -2.04 Million | - | -794 Thousand | - | -3.63 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | 601.62 Million |
| Other Financing Activities | -895.21 Thousand | - | -1.25 Million | - | 580.03 Million | 581.43 Million |
| Accounts receivables | - | 4.05 Million | 4.05 Million | - | -12.02 Million | -12.02 Million |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | -12.02 Million | -12.02 Million | - | -23.99 Million | -23.99 Million |
| Other working capital | - | 3.46 Million | 3.46 Million | - | -18.96 Million | -18.96 Million |
| Cash at beginning of period | 1.21 Billion | 944.51 Million | 1.06 Billion | 944.51 Million | 664.53 Million | 713.48 Million |
| Cash at end of period | 1.08 Billion | 1.21 Billion | 1.21 Billion | 1.06 Billion | 944.51 Million | 944.51 Million |
| Capital Expenditure | -31 Million | -86.74 Million | -1.86 Million | -1.2 Million | -3.82 Million | -83.36 Million |
| Effect of forex changes on cash | 634.96 Thousand | -6 Million | -3.1 Million | -2.9 Million | -9.68 Million | -6.29 Million |
| Net cash flow / Change in cash | -127.78 Million | 267.51 Million | 145.69 Million | 121.82 Million | 279.98 Million | 231.03 Million |
| Free Cash Flow | 72.48 Million | 77.51 Million | 100.73 Million | 60.45 Million | 9.04 Million | -17.82 Million |
1971
3565
BGJL
VIRT
GMT
SVT